Search

Displaying results 9481 - 9490 of 10000 in total
  1. Drug

    Eberconazole

    go.drugbank.com/drugs/DB13656
    Investigational

    Eberconazole is a broad-spectrum imidazole derivative.[A275078]

    Categories: Heterocyclic Compounds, 1-RingProducts: EBERNET % 1 KREM (30 G)
  2. Drug

    Isospaglumic acid

    go.drugbank.com/drugs/DB19650
    Investigational

    Isospaglumic acid is a small molecule drug. … Isospaglumic acid is under investigation in clinical trial NCT06800274 (Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film Dysfunction).

    Synonyms: N-acetylaspartylglutamic acid
  3. Drug

    Glovadalen

    go.drugbank.com/drugs/DB21709
    Investigational

    Glovadalen is under investigation in clinical trial NCT06970301 (A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants) … Glovadalen is a small molecule drug.

  4. Drug

    Pigment epithelium-derived factor 34

    go.drugbank.com/drugs/DB33941
    Experimental

    Pigment epithelium-derived factor 34 is a biologic drug. … Pigment epithelium-derived factor 34 is under investigation in clinical trial NCT07811726 (The Purpose of This Study is to Evaluate Efficacy and Safety of NT-101 Eye Drops in Patients With Wet Age-Related

  5. Drug

    Acetyldinaline

    go.drugbank.com/drugs/DB16142
    Investigational

    Acetyldinaline is under investigation in clinical trial NCT00005624 (CI-994 in Treating Patients With Advanced Myeloma).

  6. Drug

    CM-4307

    go.drugbank.com/drugs/DB15414
    Investigational

    CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).

    Categories: Heterocyclic Compounds, 1-Ring
  7. Drug

    Izuralimab

    go.drugbank.com/drugs/DB18933
    Investigational

    Izuralimab is under investigation in clinical trial NCT05879185 (A Study of Xmab23104 in People With Sarcoma).

    Synonyms: IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS ICOS (INDUCIBLE T-CELL COSTIMULATORY, ACTIVATION-INDUCIBLE LYMPHOCYTE IMMUNOMEDIATORY MOLECULE, AILIM, CD278)) AND ANTI-(HOMO SAPIENS, PDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), M
  8. Drug

    GLPG-0492

    go.drugbank.com/drugs/DB12461
    Investigational

    Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).

    Categories: Heterocyclic Compounds, 1-Ring
  9. Drug

    Ancriviroc

    go.drugbank.com/drugs/DB19773
    Experimental

    Ancriviroc is a small molecule drug. The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist. … Ancriviroc has a monoisotopic molecular weight of 556.2 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  10. Drug

    Nigella sativa oil

    go.drugbank.com/drugs/DB28165
    Investigational

    Nigella Sativa Oil is a biologic drug. … Nigella Sativa Oil is under investigation in clinical trial NCT06823544 (A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis